{"id":"https://openalex.org/W2113971256","doi":"https://doi.org/10.1158/1535-7163.mct-07-0552","title":"Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization","display_name":"Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization","alternate_titles":[],"publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2113971256","doi":"https://doi.org/10.1158/1535-7163.mct-07-0552","mag":"2113971256","pmid":"https://pubmed.ncbi.nlm.nih.gov/18187807"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-07-0552","doi":"https://doi.org/10.1158/1535-7163.mct-07-0552","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-07-0552","pdf_url":"https://aacrjournals.org/mct/article-pdf/7/1/71/1877083/71.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2113971256"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/mct/article-pdf/7/1/71/1877083/71.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030947676","display_name":"An Claes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"An Claes","raw_affiliation_strings":["1Pathology and Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pathology and Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050961926","display_name":"Pieter Wesseling","orcid":"https://orcid.org/0000-0001-5453-5201","observed_orcids":["https://orcid.org/0000-0001-5453-5201"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pieter Wesseling","raw_affiliation_strings":["1Pathology and Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pathology and Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111681272","display_name":"Judith W. M. Jeuken","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Judith Jeuken","raw_affiliation_strings":["1Pathology and Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pathology and Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013281130","display_name":"Cathy Maass","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cathy Maass","raw_affiliation_strings":["1Pathology and Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pathology and Departments of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077895949","display_name":"Arend Heerschap","orcid":"https://orcid.org/0000-0001-9930-4562","observed_orcids":["https://orcid.org/0000-0001-9930-4562"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arend Heerschap","raw_affiliation_strings":["2Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019822912","display_name":"William P. J. Leenders","orcid":"https://orcid.org/0000-0003-0066-220X","observed_orcids":["https://orcid.org/0000-0003-0066-220X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William P.J. Leenders","raw_affiliation_strings":["1Pathology and Departments of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Pathology and Departments of","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.9031,"has_fulltext":true,"cited_by_count":114,"citation_normalized_percentile":{"value":0.98442006,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"7","issue":"1","first_page":"71","last_page":"78"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.489300012588501,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.489300012588501,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.45969998836517334,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.03350000083446503,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9829999804496765},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9769999980926514},{"id":"https://openalex.org/keywords/vandetanib","display_name":"vandetanib","score":0.921999990940094},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":1.0},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.6869999766349792},{"id":"https://openalex.org/keywords/vessel-normalization","display_name":"vessel normalization","score":0.8759999871253967},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.546999990940094},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.4959999918937683},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7580000162124634},{"id":"https://openalex.org/keywords/brain-tumors","display_name":"brain tumors","score":0.5529999732971191},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.8324191570281982},{"id":"https://openalex.org/C2780333294","wikidata":"https://www.wikidata.org/wiki/Q7914515","display_name":"Vandetanib","level":4,"score":0.8228861689567566},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6955113410949707},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6002078056335449},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5950589776039124},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5765165686607361},{"id":"https://openalex.org/C2779130545","wikidata":"https://www.wikidata.org/wiki/Q233309","display_name":"Brain tumor","level":2,"score":0.5605044960975647},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.5487327575683594},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5045446157455444},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4902418255805969},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4864623248577118},{"id":"https://openalex.org/C2776056115","wikidata":"https://www.wikidata.org/wiki/Q574834","display_name":"Angiogenesis inhibitor","level":3,"score":0.4360314607620239},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4042370915412903},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.35473209619522095},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32953059673309326},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3073797821998596},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.14346346259117126},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.10172015428543091},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077204","descriptor_name":"Temozolomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003606","descriptor_name":"Dacarbazine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003606","descriptor_name":"Dacarbazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-07-0552","doi":"https://doi.org/10.1158/1535-7163.mct-07-0552","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-07-0552","pdf_url":"https://aacrjournals.org/mct/article-pdf/7/1/71/1877083/71.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:18187807","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18187807","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:repository.ubn.ru.nl:2066/69825","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2066/69825","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer Therapeutics, 7, 1, pp. 71-8","raw_type":"Article / Letter to editor"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.mct-07-0552","doi":"https://doi.org/10.1158/1535-7163.mct-07-0552","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-07-0552","pdf_url":"https://aacrjournals.org/mct/article-pdf/7/1/71/1877083/71.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5902404354","display_name":"MR upgrade and extension with NIRS for mouse brain studies","funder_award_id":"834.04.007","funder_id":"https://openalex.org/F4320321800","funder_display_name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320321800","display_name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","ror":"https://ror.org/04jsz6e67"},{"id":"https://openalex.org/F4320325060","display_name":"Hersenstichting","ror":"https://ror.org/04y8met08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2113971256.pdf","grobid_xml":"https://content.openalex.org/works/W2113971256.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W72344367","https://openalex.org/W308026507","https://openalex.org/W1265988497","https://openalex.org/W1537447319","https://openalex.org/W1567768016","https://openalex.org/W1969328947","https://openalex.org/W1969367931","https://openalex.org/W1999966784","https://openalex.org/W2004144303","https://openalex.org/W2006202974","https://openalex.org/W2023692811","https://openalex.org/W2031376430","https://openalex.org/W2046507292","https://openalex.org/W2057149384","https://openalex.org/W2067055586","https://openalex.org/W2082572214","https://openalex.org/W2096228923","https://openalex.org/W2096893939","https://openalex.org/W2099087398","https://openalex.org/W2104387616","https://openalex.org/W2118559000","https://openalex.org/W2142412446","https://openalex.org/W2144108543","https://openalex.org/W2147535764","https://openalex.org/W2154451644","https://openalex.org/W2157769714","https://openalex.org/W2166825418"],"related_works":["https://openalex.org/W2015642017","https://openalex.org/W2918400576","https://openalex.org/W2739763830","https://openalex.org/W2011249040","https://openalex.org/W2024831249","https://openalex.org/W2026514919","https://openalex.org/W2037408509","https://openalex.org/W2588470637","https://openalex.org/W4366237940","https://openalex.org/W1595968358"],"abstract_inverted_index":{"Glioblastomas":[0],"are":[1],"highly":[2],"aggressive":[3],"primary":[4,86],"brain":[5,87,94],"tumors.":[6],"Curative":[7],"treatment":[8],"by":[9,185],"surgery":[10],"and":[11,37,163,175,190],"radiotherapy":[12],"is":[13,34,78,200],"generally":[14],"impossible":[15],"due":[16],"to":[17,64,133,194,208],"the":[18,26,100,105,124,165,180,188,206],"presence":[19],"of":[20,45,99,107,123,138,161,182,187,192,226],"diffusely":[21],"infiltrating":[22],"tumor":[23,32,71,195,198],"cells.":[24,196],"Furthermore,":[25,177],"blood-brain":[27],"barrier":[28],"(BBB)":[29],"in":[30,47,69,93,97,152,212,229],"infiltrative":[31,173],"areas":[33],"largely":[35],"intact,":[36],"this":[38,111,115],"hampers":[39],"chemotherapy":[40],"as":[41],"well.":[42],"The":[43,197],"occurrence":[44],"angiogenesis":[46,141],"these":[48,51],"tumors":[49,52,88],"makes":[50],"attractive":[53],"candidates":[54],"for":[55,85,104,205],"antiangiogenic":[56,59,209,214],"therapies.":[57],"Because":[58],"compounds":[60,68,215,228],"have":[61,217],"been":[62],"shown":[63],"synergize":[65],"with":[66,102,120,135,222],"chemotherapeutic":[67,108],"other":[70],"types,":[72],"based":[73],"on":[74],"vessel":[75,91],"normalization,":[76],"there":[77],"a":[79,149],"tendency":[80],"toward":[81],"such":[82,227],"combination":[83,150],"therapies":[84],"also.":[89],"However,":[90],"normalization":[92],"may":[95,216],"result":[96],"restoration":[98,186],"BBB":[101,189],"consequences":[103],"efficacy":[106],"agents.":[109],"In":[110],"study,":[112],"we":[113],"investigated":[114],"hypothesis.":[116],"BALB/c":[117],"nude":[118],"mice":[119],"intracerebral":[121],"xenografts":[122],"human":[125],"glioblastoma":[126],"lines":[127],"E98":[128],"or":[129,148],"U87":[130],"were":[131],"subjected":[132],"therapy":[134],"different":[136],"dosages":[137],"vandetanib":[139,178],"(an":[140],"inhibitor),":[142],"temozolomide":[143,183],"(a":[144],"DNA":[145],"alkylating":[146],"agent),":[147],"(n>8":[151],"each":[153],"group).":[154],"Vandetanib":[155],"selectively":[156],"inhibited":[157],"angiogenic":[158],"growth":[159,174],"aspects":[160],"glioma":[162],"restored":[164],"BBB.":[166],"It":[167],"did":[168],"not":[169],"notably":[170],"affect":[171],"diffuse":[172],"survival.":[176],"antagonized":[179],"effects":[181,219],"presumably":[184],"obstruction":[191],"chemodistribution":[193],"microenvironment":[199],"an":[201],"extremely":[202],"important":[203],"determinant":[204],"response":[207],"therapy.":[210],"Particularly":[211],"brain,":[213],"adverse":[218],"when":[220],"combined":[221],"chemotherapy.":[223],"Thus,":[224],"use":[225],"neuro-oncology":[230],"should":[231],"be":[232],"reconsidered.":[233]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2113971256","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
